17063-Melanoma-NA-580

Melanoma

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors (4020-01-001)

  • Details

ClinicalTrials.gov ID: NCT02817633
Diagnosis Type: NA
USOR Number: 17063

  • Address

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.